Association between metabolic syndrome, fatty liver disease, and gastrointestinal tumors: a population-based study with external validation
This study confirms that MetS is strongly associated with FLD risk and GIT incidence, supporting early metabolic intervention to interrupt the progression of liver disease and tumors.
Authors
- Mengyao Zhang (ORCID: https://orcid.org/0009-0004-9317-8218)
- Zhenjing Jin (ORCID: https://orcid.org/0009-0003-6210-4526)
- Jie Song (ORCID: https://orcid.org/0000-0002-9077-141X)
- Lanlan Yang
- Qian Zhang
- Siqi Liu
Institutions
- Second Affiliated Hospital of Jilin University (CN)
Publication Details
- Journal
- Frontiers in Nutrition
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3389/fnut.2026.1706013
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00